Related Experiment Video
Updated: Feb 28, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
eHealth Technologies as an intervention to improve adherence to topical antipsoriatics: a systematic review
Mathias Tiedemann Svendsen1,2,3, Flemming Andersen1,2, Klaus Ejner Andersen1,2,3
1a Department of Dermatology and Allergy Centre , Odense University Hospital , Odense C , Denmark.
Background:
Topical antipsoriatics are recommended first-line treatment of psoriasis, but rates of adherence are low. Patient support by use of electronic health (eHealth) services is suggested to improve medical adherence.
Objective:
To review randomised controlled trials (RCTs) testing eHealth interventions designed to improve adherence to topical antipsoriatics and to review applications for smartphones (apps) incorporating the word psoriasis.
Material And Methods:
Literature review: Medline, Embase, Cochrane, PsycINFO and Web of Science were searched using search terms for eHealth, psoriasis and topical antipsoriatics. General analysis of apps: The operating systems (OS) for smartphones, iOS, Google Play, Microsoft Store, Symbian OS and Blackberry OS were searched for apps containing the word psoriasis.
Results:
Literature review: Only one RCT was included, reporting on psoriasis patients' Internet reporting their status of psoriasis over a 12-month period. The rate of adherence was measured by Medication Event Monitoring System (MEMS®). An improvement in medical adherence and reduction of severity of psoriasis were reported. General analysis of apps: A total 184 apps contained the word psoriasis.
Conclusion:
There is a critical need for high-quality RCTs testing if the ubiquitous eHealth technologies, for example, some of the numerous apps, can improve psoriasis patients' rates of adherence to topical antipsoriatics.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Hand hygiene
Hand washing...
Ophthalmic Drug Delivery Systems
Bioavailability Enhancement: Drug Permeability Enhancement
Oral Drug Delivery Systems: Introduction
Modified-Release Drug Delivery Systems: Site-Targeted

